PRESS RELEASE published on 07/23/2025 at 09:05, 6 months 13 days ago BioNxt Delivers Positive Results in Patented Cladribine Sublingual Thin-Film Program and Completes Successful Formulation BioNxt Solutions Inc. announces successful development of sublingual thin-film prototype for cladribine-based drug delivery in multiple sclerosis treatment, strengthening clinical development path BioNxt Solutions Inc. Cladribine Drug Delivery Multiple Sclerosis Treatment Thin-film Prototype
BRIEF published on 07/12/2025 at 00:05, 6 months 24 days ago BioNxt Solutions Proposes Convertible Debenture Unit Offering Private Placement Convertible Debenture Investor Information Product Development BioNxt Solutions
BRIEF published on 07/12/2025 at 00:05, 6 months 24 days ago BioNxt Solutions propose une offre d'unités d'obligations convertibles Placement Privé Développement De Produits Informations Pour Les Investisseurs Obligation Convertible Solutions BioNxt
PRESS RELEASE published on 07/12/2025 at 00:00, 6 months 24 days ago BioNxt Solutions Announces Convertible Debenture Unit Private Placement BioNxt Solutions Inc. announces $1.2M non-brokered private placement of convertible debenture units for product development and commercialization Private Placement Convertible Debentures BioNxt Solutions Inc. Commercialization Product Development
BRIEF published on 07/09/2025 at 03:32, 6 months 27 days ago BioNxt Solutions innove dans l'administration ciblée de médicaments de chimiothérapie Oncologie De Précision Solutions BioNxt Administration De Médicaments Innovations Pharmaceutiques Chimiothérapie Ciblée
BRIEF published on 07/09/2025 at 03:32, 6 months 27 days ago BioNxt Solutions Innovates Targeted Chemotherapy Drug Delivery Precision Oncology Drug Delivery BioNxt Solutions Pharmaceutical Innovations Targeted Chemotherapy
PRESS RELEASE published on 07/09/2025 at 03:27, 6 months 27 days ago BioNxt Solutions Introduces Targeted Chemotherapy Drug Delivery Platform for Precision Oncology BioNxt Solutions Inc. announces breakthrough targeted chemotherapy delivery platform for precision oncology, focusing on tumor-specific drug release and neutralization mechanism Precision Oncology BioNxt Solutions Inc. Drug Delivery Targeted Chemotherapy Chemotherapy Market
BRIEF published on 07/07/2025 at 09:10, 6 months 29 days ago BioNxt fait progresser le programme de cladribine sublinguale pour la sclérose en plaques Développement Pharmaceutique Solutions BioNxt Cladribine Sublinguale Conformité Des Patients Traitement De La Sclérose En Plaques
BRIEF published on 07/07/2025 at 09:10, 6 months 29 days ago BioNxt Advances Sublingual Cladribine Program for MS Pharmaceutical Development Multiple Sclerosis Treatment BioNxt Solutions Sublingual Cladribine Patient Compliance
PRESS RELEASE published on 07/07/2025 at 09:05, 6 months 29 days ago BioNxt's Sublingual Cladribine Program for MS Ready for Next Phase BioNxt Solutions receives cladribine API for BNT23001 sublingual thin-film formulation treating multiple sclerosis. Initiates clinical batch production with European partner Gen-Plus GmbH & Co KG Multiple Sclerosis BioNxt Solutions BNT23001 Cladribine API Sublingual Film
Published on 02/05/2026 at 18:50, 2 hours 14 minutes ago Athena Gold Provides Exploration Update From Nevada and Ontario
Published on 02/05/2026 at 17:35, 3 hours 29 minutes ago Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 4 hours 24 minutes ago Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 5 hours 19 minutes ago American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 5 hours 54 minutes ago Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 19:27, 1 hour 36 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 2 hours 18 minutes ago EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 2 hours 55 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 3 hours 9 minutes ago Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 3 hours 24 minutes ago BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 19:15, 1 hour 49 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 1 hour 49 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 1 hour 49 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
